ES2075437T3 - Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene. - Google Patents

Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene.

Info

Publication number
ES2075437T3
ES2075437T3 ES91907075T ES91907075T ES2075437T3 ES 2075437 T3 ES2075437 T3 ES 2075437T3 ES 91907075 T ES91907075 T ES 91907075T ES 91907075 T ES91907075 T ES 91907075T ES 2075437 T3 ES2075437 T3 ES 2075437T3
Authority
ES
Spain
Prior art keywords
new derivative
pct
oraposide
cosmetic
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907075T
Other languages
English (en)
Inventor
Claude Andary
Patrice Andre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parfums Christian Dior SA
Original Assignee
Parfums Christian Dior SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parfums Christian Dior SA filed Critical Parfums Christian Dior SA
Application granted granted Critical
Publication of ES2075437T3 publication Critical patent/ES2075437T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION CONCIERNE A UN NUEVO DERIVADO DEL ACIDO CAFEICO. ESTE NUEVO DERIVADO PRESENTA LA FORMULA (I) EN LA CUAL UNO O VARIOS R REPRESENTAN INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO EN C1-C5, EN PARTICULAR METILO, UN GRUPO ACILO, EN PARTICULAR EN C1-C6, SOBRE TODO ACETILO. ESTE NUEVO DERIVADO DENOMINADO ORAPOXIDO ES PARTICULARMENTE UTIL PARA LA PREPARACION DE COMPOSICIONES COSMETICAS O FARMACEUTICAS, EN PARTICULAR DERMATOLOGICAS, GRACIAS SOBRE TODO A UNA ACTIVIDAD ANTIRADICALES LIBRES, ANTIINFLAMATORIAS Y ANTIENVEJECIMIENTO ACTINICO.
ES91907075T 1991-03-21 1991-03-21 Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene. Expired - Lifetime ES2075437T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1991/000229 WO1992016544A1 (fr) 1991-03-21 1991-03-21 Nouveau derive de l'acide cafeique, l'oraposide, composition cosmetique ou pharmaceutique, notamment dermatologique le contenant

Publications (1)

Publication Number Publication Date
ES2075437T3 true ES2075437T3 (es) 1995-10-01

Family

ID=34834297

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907075T Expired - Lifetime ES2075437T3 (es) 1991-03-21 1991-03-21 Nuevo derivado del acido cafeico, el oraposido, composicion cosmetica o farmaceutica, particularmente dermatologica que lo contiene.

Country Status (10)

Country Link
US (1) US5719129A (es)
EP (1) EP0576420B1 (es)
JP (1) JP3147900B2 (es)
KR (1) KR100194830B1 (es)
AT (1) ATE123287T1 (es)
AU (1) AU670742B2 (es)
CA (1) CA2102689A1 (es)
DE (1) DE69110136T2 (es)
ES (1) ES2075437T3 (es)
WO (1) WO1992016544A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4444238A1 (de) * 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
DE19615575A1 (de) * 1996-04-19 1997-10-23 Beiersdorf Ag Verwendung von Glucosiden und Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
US6696407B1 (en) 1997-03-21 2004-02-24 The Regents Of The University Of California Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF
AU6473898A (en) * 1997-03-21 1998-10-20 Regents Of The University Of California, The Methods for modulating neurotrophic factor-associated activity using aldose reductase inhibitors
US6679584B2 (en) * 1997-07-15 2004-01-20 Silverbrook Research Pty Ltd. High volume pagewidth printing
US8466109B2 (en) * 1998-10-05 2013-06-18 Laboratoires Expanscience Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology
AU1041800A (en) * 1998-11-02 2000-05-22 Ciba Specialty Chemicals Holding Inc. Stabilisation of body-care and household products
FR2787996B1 (fr) * 1998-12-30 2002-05-10 Dior Christian Parfums Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique
US20040228816A1 (en) * 1998-12-30 2004-11-18 Carine Nizard Cosmetic or dermatological composition containing an active agent which stimulates synthesis of the protein HSP 32 in the skin
IT1317732B1 (it) * 2000-01-20 2003-07-15 Giuliani Spa Composti ad attivita' antiossidante, composizioni utili qualiintegratori alimentari che li contengono e procedimento per
US6437004B1 (en) 2000-04-06 2002-08-20 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
EP1166765A3 (de) * 2000-06-20 2002-05-02 Laboratoires Serobiologiques Verfahren zum Schutz der menschlichen Haut
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
JP3820218B2 (ja) * 2000-09-01 2006-09-13 クレアグリ， インコーポレイテッド 植物水からヒドロキシチロソール富化組成物を得る方法
EP1260212A1 (de) * 2001-05-21 2002-11-27 Cognis France S.A. Kosmetische Mittel
JP2002363075A (ja) 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
WO2003068171A2 (en) * 2002-02-13 2003-08-21 Creagri, Inc. Method and composition for treatment of inflammation and aids-associated neurological disorders
DE10215055A1 (de) * 2002-04-03 2003-10-30 Univ Schiller Jena Verwendung von Kaffeesäureestern zur Herstellung von kosmetischen nutrazeutischen sowie pharmazeutischen Präparaten und Arzneimitteln
US6989162B2 (en) * 2003-03-31 2006-01-24 Council Of Scientific & Industrial Research Hepatoprotective agent of plant origin and a process thereof
ATE376426T1 (de) * 2003-03-31 2007-11-15 Council Scient Ind Res Isolierung des hepatoprotektiven wirkstoffes acteosid aus colerbrookea oppositifolia
US20060020029A1 (en) * 2004-07-02 2006-01-26 Shimasaki Craig D Pharmaceutical compositions from ethnobotanicals
JP2008509224A (ja) * 2004-08-09 2008-03-27 クレアグリ， インコーポレイテッド 炎症状態を治療するためのオリーブ組成物及び方法
US9789149B2 (en) * 2005-07-19 2017-10-17 Creagri, Inc. Vegetation water composition for treatment of inflammatory skin conditions
FR2892923B1 (fr) * 2005-11-08 2009-01-16 Engelhard Lyon Sa Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
WO2008083389A1 (en) * 2006-12-29 2008-07-10 Moleculin, L.L.C. Methods of treating skin disorders with caffeic acid analogs
WO2008093678A1 (ja) * 2007-01-29 2008-08-07 Oryza Oil & Fat Chemical Co., Ltd. ヒアルロニダーゼ阻害剤
JP2009263279A (ja) * 2008-04-25 2009-11-12 Oriza Yuka Kk エラスターゼ阻害剤
US8450337B2 (en) * 2008-09-30 2013-05-28 Moleculin, Llc Methods of treating skin disorders with caffeic acid analogs
WO2012143017A1 (en) 2011-04-17 2012-10-26 El-Sawy Mohamed Fakhr El-Din The use of orobancheace extract for the treatment of hepatitis c virus and nonalcoholic fatty liver disease
GB201705403D0 (en) * 2017-04-04 2017-05-17 Givaudan Sa Improvements in or relating to organic compounds
CN109776633B (zh) * 2019-03-18 2020-08-04 暨南大学 一种苯丙素类化合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314725A1 (fr) * 1975-03-07 1977-01-14 Screen Procede pour la preparation d'heterosides de dihydroxyphenylalcanol et medicaments contenant de tels heterosides
FR2302745A1 (fr) * 1975-03-07 1976-10-01 Screen Esters heterosidiques d'acide cafeique, leurs procedes de preparation e
FR2652086B1 (fr) * 1989-09-20 1993-05-21 Andary Claude Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.

Also Published As

Publication number Publication date
EP0576420A1 (fr) 1994-01-05
AU7585091A (en) 1992-10-21
JP3147900B2 (ja) 2001-03-19
US5719129A (en) 1998-02-17
CA2102689A1 (fr) 1992-09-22
KR100194830B1 (ko) 1999-06-15
ATE123287T1 (de) 1995-06-15
DE69110136T2 (de) 1996-01-11
DE69110136D1 (de) 1995-07-06
JPH06508601A (ja) 1994-09-29
WO1992016544A1 (fr) 1992-10-01
EP0576420B1 (fr) 1995-05-31
AU670742B2 (en) 1996-08-01

Similar Documents

Publication Publication Date Title
AU7585091A (en) Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
ES2084808T3 (es) Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas.
ES2069388T3 (es) Derivados s-triazinicos que llevan sustituyentes benzalmalonatos, su procedimiento de preparacion, composiciones cosmeticas filtrantes que los contienen, y su empleo para proteger la piel y los cabellos de las radiaciones ultravioleta.
ES2113416T3 (es) Derivados s-triazinicos que llevan sustituyentes benciliden-alcanfor, su procedimiento de preparacion, composiciones cosmeticas filtrantes que los contienen y su utilizacion para proteger la piel y los cabellos de la radiacion ultravioleta.
MX9300821A (es) Compuestos hipolipidemicos.
EP0547727A3 (en) Skin and hands composition containing disinfectants and antiseptics
DK0553241T3 (da) Anvendelse af sammensætninger på basis af fedtalkoholer til fremstilling af emulsioner, fremgangsmåd e til fremstilling af emulsioner og således fremstillede emulsioner
AR037329A1 (es) Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos
AR029383A1 (es) Moleculas pequenas, los intermediarios para su sintesis, las composiciones farmaceuticas que las contienen y su uso para preparar un medicamento destinado al tratamiento o la profilaxis de enfermedades inflamatorias o mediadas por celulas inmunes
MX9202166A (es) Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
NO880995D0 (no) Nye 5-alkoxy-2,4-diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen.
DE69515183D1 (de) Hypolipidämische benzothiazepine
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
ES2098004T3 (es) Peptidos derivados de trifluoro-metil-cetonas con una actividad inhibidora de la elastasa leucocitaria humana (hle), su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9204525A (es) Derivados de 4-benzoil-isoxasol, procedimiento para su preparacion y composicion herbicida que los contiene
MX9304579A (es) Derivados de 4-aza-5alfa-androstan-3-ona 17beta-substituidos, fluorados, proceso para su preparaciony composicion farmaceutica que los comprende.
ES2084371T3 (es) Composiciones cosmeticas que contienen un extracto de eclipta alba.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
AR012546A1 (es) Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida.
ES2129112T3 (es) Compuestos aromaticos policiclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
MX9300840A (es) Compuestos farmaceuticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
HN1997000070A (es) Inhibición de las metaloproteinasas de matriz por acidos 2-((1)-aroilalquil) -4-biaril-4-oxoburiticos
ES2069719T3 (es) Nuevos derivados de tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69413831D1 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 576420

Country of ref document: ES